Diseases, Conditions, Syndromes

Moderna reports positive results for RSV vaccine

US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.

Diseases, Conditions, Syndromes

XBB.1.5 could be dominant in Europe soon: health agency

Omicron subvariant XBB.1.5, which now accounts for a quarter of US Covid-19 cases, could become the dominant strain in Europe within a few months, the EU's disease agency said Friday.

Health

Asthma study sparks debate about safety of cooking with gas

New research that links cooking with natural gas to around 12 percent of childhood asthma cases has sparked debate about the health risks of kitchen stoves, as well as calls in the United States for stepped-up regulation.

Diseases, Conditions, Syndromes

EU's COVID pass worked well, other tools less so: auditors

The EU's COVID pass system worked well to allow continued free movement in the bloc during the coronavirus pandemic, but other tools fared worse, the European Court of Auditors said Wednesday.

Oncology & Cancer

EU approves treatment for prostate cancer

The European Union has approved a new treatment against an advanced type of prostate cancer by Novartis, the Swiss pharmaceutical giant said Tuesday.

Vaccination

Japanese dengue vaccine becomes second approved by EU

Japanese pharmaceutical company Takeda said the European Union had given the green light to its dengue fever vaccine, making it the second jab preventing the disease to be approved by the bloc.

page 6 from 40